Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.

Top 25 shareholders own 76.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.2%	Frazier Life Sciences Management, LP	38,675,501	SEK 214.6m	0%	1.03%
11.5%	Cetoros AB	33,776,221	SEK 187.5m	0%	no data
10.3%	Peter Lindell	30,007,682	SEK 166.5m	0%	no data
7.32%	Fourth Swedish National Pension Fund (AP4)	21,404,690	SEK 118.8m	0%	0.04%
6.04%	Avla Holding AB	17,668,330	SEK 98.1m	0%	no data
4.73%	Flerie AB (publ)	13,844,458	SEK 76.8m	0%	12.04%
4.61%	Thomas Eldered	13,499,458	SEK 74.9m	0%	no data
4.04%	Handelsbanken Asset Management	11,831,897	SEK 65.7m	0%	0.01%
3.6%	Recipharm AB (publ)	10,531,660	SEK 58.5m	0%	no data
2.57%	Linc AB	7,532,021	SEK 41.8m	0%	1.86%
2.37%	Unionen, Endowment Arm	6,946,793	SEK 38.6m	0%	1.14%
1.82%	Avanza Fonder AB	5,335,379	SEK 29.6m	0%	0.07%
1.2%	Carl Rosvall	3,520,287	SEK 19.5m	0%	no data
1.07%	Mats Blom	3,134,762	SEK 17.4m	0%	no data
0.52%	SEB Investment Management AB	1,519,937	SEK 8.4m	5.19%	no data
0.39%	Healthinvest Partners AB	1,129,177	SEK 6.3m	0%	0.24%
0.27%	AXA Investment Managers S.A.	802,650	SEK 4.5m	0%	no data
0.25%	FCG Fonder AB	743,133	SEK 4.1m	0%	0.05%
0.12%	Henrik Krook	339,593	SEK 1.9m	0%	no data
0.1%	Yilmaz Mahshid	303,089	SEK 1.7m	0%	no data
0.097%	Thomas Lonngren	283,158	SEK 1.6m	-0.03%	no data
0.095%	Medical Strategy GmbH, Asset Management Arm	277,000	SEK 1.5m	0%	0.01%
0.079%	Nicklas Westerholm	232,576	SEK 1.3m	9.2%	no data
0.042%	Skandia Fonder AB	121,862	SEK 676.3k	0%	no data
0.014%	Gunilla Osswald	40,000	SEK 222.0k	0%	no data